Evidence map›Paper›PMID 36145282›Full record

ArticlePharmaceuticals (Basel, Switzerland)2022

Nitrostilbenes: Synthesis and Biological Evaluation as Potential Anti-Influenza Virus Agents.

Marta De Angelis, Barbara De Filippis, Marwa Balaha, Letizia Giampietro, Mariya Timotey Miteva, Giovanna De Chiara, Anna Teresa Palamara, Lucia Nencioni, Adriano Mollica

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Marta De AngelisLaboratory Affiliated to Institute, Department of Public Health and Infectious Diseases, Pasteur Italia-Cenci Bolognetti Foundation, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-1916-6508
Barbara De FilippisDepartment of Pharmacy, University "G. d'Annunzio" University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0001-7718-5814
Marwa BalahaDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El Sheikh 33516, Egypt.ORCID 0000-0001-8042-6009
Letizia GiampietroDepartment of Pharmacy, University "G. d'Annunzio" University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0002-8483-1885
Mariya Timotey MitevaLaboratory Affiliated to Institute, Department of Public Health and Infectious Diseases, Pasteur Italia-Cenci Bolognetti Foundation, Sapienza University of Rome, 00185 Rome, Italy.
Giovanna De ChiaraInstitute of Translational Pharmacology, National Research Council, 00133 Rome, Italy.ORCID 0000-0002-2219-6097
Anna Teresa PalamaraLaboratory Affiliated to Institute, Department of Public Health and Infectious Diseases, Pasteur Italia-Cenci Bolognetti Foundation, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0001-8330-4381
Lucia NencioniLaboratory Affiliated to Institute, Department of Public Health and Infectious Diseases, Pasteur Italia-Cenci Bolognetti Foundation, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0003-4427-4823
Adriano MollicaDepartment of Pharmacy, University "G. d'Annunzio" University of Chieti-Pescara, via dei Vestini 31, 66100 Chieti, Italy.ORCID 0000-0002-7242-4860
Istituto Pasteur · ITUniversity of Chieti-Pescara · ITIstituto di Farmacologia Traslazionale · ITKafrelsheikh University · EG

Funding

FAR Italian Ministry for Instruction, University and Research 2020Istituto Pasteur Anna Tramontano 2019Ministry of Education, Universities and Research MIUR PRIN: 501 2017BMK8JR006Sapienza University of Rome Ateneo 2021
6 · The paper itself

Abstract

Resveratrol (RSV) is a natural stilbene polyphenolic compound found in several plant species. It is characterized by antioxidant properties, and its role in controlling viral replication has been demonstrated for different viral infections. Despite its promising antiviral properties, RSV biological activity is limited by its low bioavailability and high metabolic rate. In this study, we optimized its structure by synthesizing new RSV derivatives that maintained the phenolic scaffold and contained different substitution patterns and evaluated their potential anti-influenza virus activity. The results showed that viral protein synthesis decreased 24 h post infection; particularly, the nitro-containing compounds strongly reduced viral replication. The molecules did not exert their antioxidant properties during infection; in fact, they were not able to rescue the virus-induced drop in GSH content or improve the antioxidant response mediated by the Nrf2 transcription factor and G6PD enzyme. Similar to what has already been reported for RSV, they interfered with the nuclear-cytoplasmic traffic of viral nucleoprotein, probably inhibiting cellular kinases involved in the regulation of specific steps of the virus life cycle. Overall, the data indicate that more lipophilic RSV derivatives have improved antiviral efficacy compared with RSV and open the way for new cell-targeted antiviral strategies.

Indexed as

antiviralsinfluenza viruspolyphenolsredox stateresveratrol

Identifiers

PMID36145282
PMCPMC9505218
OpenAlexW4293769460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.